The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis

NACompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

December 6, 2023

Study Completion Date

January 31, 2024

Conditions
PancreatitisCholangiopancreatography, Endoscopic RetrogradeIndomethacin
Interventions
DRUG

Indomethacin Suppository

Patients in the regular dose group are given indomethacin suppository 100 mg anal plug immediately after operation, patients in the low dose group are given indomethacin suppository 50 mg anal plug immediately after operation, and patients in the high dose group are given indomethacin suppository 150 mg anal plug immediately after operation.

Trial Locations (1)

215006

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
lead

The First Affiliated Hospital of Soochow University

OTHER